Nektar Therapeutics (NKTR) Lost 37c/Share in Q2

August 8, 2013 5:30 PM

Nektar Therapeutics (NASDAQ: NKTR) reported Q2 EPS of ($0.37), $0.07 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found